Philip Morris
Passive Smoking Alters Lipid Profiles in Adolescents
Fields
- Author
- Etzel, R.A.
- Feldman, J.
- Jacobson, M.S.
- Lilienfield, D.E.
- Nussbaum, M.
- Shenker, R.
- Spierto, F.W.
- Feldman, J.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- ABST, ABSTRACT
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- ABST, ABSTRACT
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Characteristic
- EXTR, EXTRA
- Site
- R529
- Named Organization
- Center for Atherosclerosis Prevention
- Long Island Jewish Medical Center
- Niehs, National Institute of Environmental Health Services/Sciences
- Schneider Childrens Hospital
- Long Island Jewish Medical Center
- Author (Organization)
- Mt Sinai School of Medicine Ny
- Pediatrics
- Schneider Childrens Hospital
- Suny Health Science Center of Brooklyn
- Albert Einstein College Med New Hyde Par
- Center for Atherosclerosis Prevention
- Center for Environ Health Injury Control
- Centers for Disease Control
- Long Island Jewish Medical Center
- Pediatrics
- Named Person
- Bader, S.
- Gardner, F.H.
- Jacobson, M.S.
- Markowski, L.
- North, B.
- Samuel, P.
- Gardner, F.H.
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- ljc02a00
Document Images
.. . ; ~° ,.
Passive Smoking Alters Li!pid Profiles in
Adolescents
Q 3
Joseph Feldman, DrPH$;, I. Ronald Shenker, MD';, Ruth A. Etzel, MD,
PhD§; Francis W. Spierto, PhD§;. David E. Lilienfield, MD, MPH,, MS,
Engin1j; Michael Nussbaum, MD*; and Marc S, Jacobson, MD'
From the 'Division of Ado/escenn. Medicine and Center for Atherosclerosis Prevenhon,
Schneider Children's Hospital of Long Island Jewish Medical Center, the Long tsland
campus for the AtbertEinstein College of, Medicine: New Hyde Park, New York;
$Depar7ment of Preventive Medicine SUNY Heatth Seience Center of 6rooklyn, New
York: §Center for Environmental Health and 1n1ury Control. Centers for Disease Control:
Atlanta, Georgia; and, pDivision, of Environmental and OccupataonalMeorcine. Mt Snal
School of Medicine, New York
ABSTRACT. Although cigarette smoking is associated',
with, elpvation of plasma lipid levels and changes in
lipoprotein~di'stribution, it, is not known whether passive
srnoking is associated with an~alteration in lipid'proftles.
The relation between plasma cotinine.a marker of ex-
posure to tobacco smoke, and lipid profiles was studied
in healthv ad'olescents from a suburban New York high
school district who were undergoing preparticipation
sports physicals. Forty-four percent of the adolescentsreported that~ one or both parents currently
smoked.
Eleven percent of the adolescents had plasma cotinine
concentrations ?2.5 ng/mL. the level considered indica-
tive of exposure. Adolescents with two smoking parents
had significantly, higher plasma cotinine concentrations
aft,err adjustment for other factors than adolescents whose
parents did not smoke. Plasma cotinine concentration
?2.5 ng/mL was associated with an 8.9°.o greater ratio of
total cholesterol to high-density lipoprotein cholesterol
(P <.003) and a 6.8 % lower high-density lipoprotein
cholesterol (P'< .03). These results suggest that passive
smoking, like active smoking,Jeadsto alterations in lipid
profiles predictive of an increased risk of atherosclerosis.
Pediatrics 1991;88:259-264; passive smoking, adolescents,
cotinine, lipid pro/iles, cholesteroL
ABBBEYIATIONS. TOTAL-C. total': cholesterol: HDL-C. hiahr
density lipoprotein cholesterol: CV. coefficient of vanaaon:
B1vlll bodv mass index: Cl, confidence intervall
Received for publication Jul 9. 1990: accepted Oct 20. 1990:
Reprint requests to IIv1.S.J.1 Center for Atherosclerosis Preven-
tion. Schneideo Children's Hospital. Room 187. Long Island
Jewish Medical Center, New H;vde Park. NY 11042.
PEDIATRICS (ISSI: 0031 40051. Copyright Z 1991 by the
American Academy of Pediatrics.
Cigarette smoking is associated with elevation of'
plasma lipid' levels and changes in lipoprotein dis-
tribution,' including an elevated ratio of total cho-
lesteroli (TOTAL,C) to liigh-density lipoprotein~
cholesterol (HDL-C).'-` The TOTAL-C/HDL-C
ratio is a: powerful predictor of the risk of' athero-
sclerotic cardiovascular disease and therefore itsrelationship to passive as well as active smokingg
has implications for pediatric atherosclerosispre-
vention.s.s
The present, study investigated the relationship
of passive smoking to lipid profidesin healthy ado.
lpscents. Cotinine. a major metabolite of nicotine.
was used as a rnarker of'passi~e exposure to tobacco
smoke. 6 We hypothesized that passive exposure to
environmental tobacco smoke as indicated bs
plasma cotinine concentration would be associated
with an increase in the TOTAL-C/HDL-C ratlio.
METHODS
As part of a required health risk assessment and
preparticipation sports physical examination non-
fasting whole blood samples were obtained! from
444 students attending suburban New York high
schools inlAugust 198T. Al] students trying out for
an athletic team at the high schools took the phys-
ical. Students were asked to complete self-admin-
istered~ questionnaires abouv their cigarette smok-
ing habits and diet. This questionnaire has previ-
ousiv been found to be reliable.9 In addition,
students were interviewed bv one of two~ authors
(J.F., M.S:J.) regarding cigarette smoking habits of
PEDIATRICS Vol. 88 No. 2 Augusti 19911 259

their parents, siblings, and friends. To improve
reliability, the first 10 interviews conducted by each
interviewer were observed by the other interviewer.
The procedures followed were approved by the Hu-
man Subjects Review Committee at Long Island
Jewish~ Medical' Center.
Passive exposure of tobacco smoke was grouped!
into five mutually exclusive categories based on~the
current cigarette smoking habits of the students'
parentssiblings, andfriends. The first three groups
below were based solely on exposure to parental'
smoking without regard to sibs or friends. The five
categories were as follows: (1)i mother smoked but
father did not, (12) father smoke& but mother did
not, (30' both, parents smoked, (4) siblings and/or
friends only smoked. and (5) no parents, siblings,
or friends smoked. Exposure from any parents not
currentliv living with the subject was excluded', Ex-
posure from smoking friends was excluded if the
student reported'spending <_2 hours per week inn
their company. Nonfasting plasma was collected by
.
venipuncture from seated subjects, centrifuged, and
frozen until analysis.
Cholesterol and triglycerides were assayed di-
rectly from 10 µL of supernatant by a Kodak mu1-
tiiaver film method. High-density lipoprotein cho-
lesterol was determined by drawing 0.5 mL of
plasma into tubes containing 50 000 molecular
weight dextran sulfate-magnesium reagent and cen-
trifuging the mixture at 1500 X g for 10 minutes to
precipitate the very-low-density lipoprotein and
low-densitv lipoprotein particles. The HDL-con-
taining supernatant was then assayed directly for
cholesterol' usiiig the Kodak multilaver film
methodl We analkzed 15 paired samples, both on a
Kodak DT60 Analyzer and at Queens Hospital
Center (New York)~Arterioscler-=is Research Lab-
oraton, which, is a participant n the Centers for
Disease Control/National Heart, Lung, and~ Blood
Instikute Lipid Standardization Program. Correla-
tion coefficients were cholesterol = .99, triglycerides
_ -9 7, and' HDL-C = .91.
Total cholesterol and HDL-C were measured in
11 batches. The coefficient of variation (CV) of
total cholesterol by batch ranged from 0.16 to 0.20
whereas for HDL-C: the CV ranged from 0:16 to
0:27. There were no significant differences in the
average levels or the variation from the averages
among the 11 batches in either males or females.
Four hundred twenty-five of the students had'suf-
ficient plasma remaining for cotinine analysis.
Plasma cotinine analysis was performed at the Di-
vision of Environmental Health Laboratory Sci-
ences at the Centers for'SDisease Control using the
radioimmuaoassay previously described by Knight
et al.10 The level of detection for cotinine in this
260 PASSIVE SMOKING AND LIPfD LEVELS
assay was 1.6 ng/mL. Cotinine and lipidiconcentra-
tions were each determined without knowledge of
reported exposure to tobacco smoke.
Notched box plots in the Figure were use& to
indicate the median cholesterol concentrations and
the 95% confidence interval about the medians. If
the notches in the boxes (ie, median ± 1.57x
interquartile range/'.ln) do not overlap, this can be
regard'e& as strong evidence that the popuiationn
medians differ...... Hatched areas in the Figure
denote the area between the 76th~and 25th per-
centile (i.e; interquartile range)i
Multiple linear analvses of covariance were per-
formed using TOTAL-C, HDL-C, and ratio of TO-
TAL-C/HDL-C as outcomes. Covariates included
age, race, sex, triglyceride concentration, and bod,~
mass index (BMI). Body mass index was calculated
byy dividing weight by the square of height. The
predictor variables were plasma cotinine concentra-
tions and self-reported passive tobacco smoke ex-
posure. Inasmuch as the distributions of both cotin-
ine and triglviceride concentrations were highl'y
skewed, these data were logarithmically trans-
formed. This transformation of the serum cotinine
levels was also useful in testing, for differences
among the exposure groups, inasmuch as the simi~
larity of the CV of cotinine among the exposure
categories (from 1.6 to 2.4) suggested proportionall
effects.'" We reporti both the arithmetic and geo-
metric means of cotinine. The constant 0.05 was
adde& to all' cotinine concentrations to avoid the
logarithm of zero which is undefined. In addition
8
2
<2:5 ng/ml >2.5 ng/mli
N
W
Figure. Lipid ratio in passive smoke-exposed andCA
nonexposed adolescents. TC., total cholesterol; HDLC)-&
high-density lipoprotein cholesterol; '. outlier values. N
R
COTININE

plasma cotinine concentrations were categorized as
<2.5 ng/mL', or ?2.5 ng/mL to indicate exposure
based on previous work.is Interactions between the
covariates and the predictor variables were exam-
ine& and none was significant. The adequacy of the
assumptions underlying the various models was
assessed by examining various residual plots."
Reanallysis omitting highly leveraged cases (ie
dropping cases with a much greater than average
impact on results) did not change any conclhsions,
The actual computations were performed using
Svstat.'6
Self-reported smokers (n- 7) were excluded. To
reduce the possibility of including current smokers
who did not report aceurately, students with~plasma
cotinine concentrations of more than 25 ng/mL (in
= 12) and nonresponders to the smoking question
(n = 2) were also excluded.~ In additionwe excluded
7 adolescents on; cholesterol-lowering diets and 6
nonresponders to the diet question. The study sam-
ple therefore consi'sted of 391 ad'olescents. The
analyses in Tables 3' and 4 were also done excluding
5 adolescents with serum cotinine values of 11 to
25 to further reduce the possibility of misclassifi-
cation of active smokers. The results were al'anost
identicali and therefore are not shown.
RESULTS
The sample included274 boys (69.7So) and 117
girls (30.3 0); Two hundred seventy-eight (71.1cio)
were white, 52' (113.2`-0Ywere black, 20 (5.1 %) were
other races, and' 41 (110.5) o) did not indicate their
race. The mean age was 14.8 ± 1.6 years; 34.3% of
the adolescents reported no smokers among their
parents, siblings, or friends; 115.1% reported that
mother smoked but father did not; 17.4% reported'
that father smoked but mother did not; 1'1.5°7o re-
ported that both parents smoked;; and 21.7% re-
ported': that siblings and/or friends only smoked.
The arithmetic mean cotinine concentration was
11.39! ng/mL (SD = 4.70), which was not signifi-
cantly different from the level of detection of the
assay: Eleven percent (n = 44) of the adolescents
had plasma cotinine concentrations -2.5 ng/mL,
89 0(n = 347) had'plasma cotinine concentrations
<2.5 ng/mL. Both the geometric and arithmetic
mean plasma cotinine concentrations were signifi-
cantly higher among adolescents who reported that
one or both parents smoked; the highest level was
found among adolescents with two smoking parents
(Table 1). Table 2 shows average levels of the ratio
of TOTAL-C/HDL-C by reported exposure and
category of serum cotinine concentration. The T0=
TAL-C/HDL-C ratio was always higher in children
whose serum cotinine level was >-2.5 ng/mL irre-
spective of reported exposure. Despite the stat!isti-
cally significant association between reponed ex-
posure and' serum cotinine concentration, it was
apparent that there was considerablp misclassifi-
cation of exposure based on self-report. Fewer than
20rc of the students in anyy reported exposure cat-
egory were classified as ezposed' based on serum
cotinine levels greater than or equall to 2.5 ng/mL
(Table 2).
Mean TOTAL-C concentration was 154 mg/dL
(SD1 = 27.2), mean HDL-C concentration was 44.6
mg/dL (SD = 10.0), and mean TOTAL-C/HDL-CC
ratio was 3.58 (SD = 1.86), The Figure shows
notched box plots for the ratio of TOTAL-CHDL-
C by cotinine group with 95% confidence intervals
about the medians. The asterisks in, the Figure
indicate observations that fall outside the 95 t
range of individual!values. The medlan TOTAL-C/
HDL-C ratio for the 44 adolescents with cotinine
concentrations ?2.5 ng/mL was significantly
.
higher than that for the 347 adolescents with cotin-
ine concentrations <2.5 ng/mL (P < .002). This
was not true for HDL-C concentrations until' co-
variates were taken into account as describe& later.
In the analysis of covariance model with outcome
equal to the ratio of TOTALC[H'DL-C; the inde-
pendent variables BMI, log triglyceride lev.el, and
log cotinine level were all significantll, associated
with the ratio (not shown). Together the variables
accounted f'or 28% of the variation in the ratio of
TOTAL-C/HDL-C, with triglyceride concentration
an& BMI accounting for 97 c7c of that amount. Re-
sults of analysis with cotinine grouped into two
categories are shown in Table 3. Cotinine level wass
significantly associated with the ratio of TOTAL-
C/HDL-C (P'<.003). IThe regression equation wass
ratio = -.60 + .038' (BMI) + ..771 ln (triglyceride)
- .324 (if cotinine level <2.5 ng/tnL) + .379 (if
white).) For the group with cotinine levels >-2.5 ng/
mLthe ratio of TOTAL-C/HDL-C on average was
.324 or 8:9 0(955o confidence interval) [C1J 6:9 %
to 11.0~'0) higher than if the cotinine level was <2.5
ng/mL. Cotinine level was significantly associated
with lower HDL-C concentration (P < .03)' (Table
4). [HDL-C = 77.8' - 5.4 In (trig)viceride) - 0:48
(BMI) + 3.0 (if cotinine leveli <2.5 ng/mLl - 2.56
(if male).J The HDL-C level, in adolescents with
plasma cotinine concentratios>-2.5 ng/mL was 3.0
mg/dL or 6.8P (95 o C1 4.6/ to 8.9ro) lower than
in those with pl'asma cotinine concentration <2.5
ng/rnL after adjustment for other factors.
The association of serum cotinine concentration
with the ratio of TOTAL-C/HDL-C was examined
separatel~, . for whites with similar results ( P=.001);
as well as for boys (P = .014) and girls (P =.001).
ARTICLES 261

TABLE 1. Arithmetic and Geometric Mean Levels and 95 % Confidence Intervals (CI)
for Serum Cotinine Levels by Reported Exposure
Reported Exposure n Arithmetic Mean
l95"c CIl' Geometric Mean
(95 c CI)
None
Friends/sibs only 134
8 7 0.55 (0.40-0.69')
1.35 (0.66-2.03) 0.07,
0.07 (0.04-0:11)
(0.04-0:14')
Mother, not father 59 1.06 (0.49-1.62) 0.13 (0.0L-0:26)1
Father, not mother 66 1.39'(0.75-2.02) 0.21 (0.11-0:39);
Both~mother and father
F ratio 4.386 dJ 45 2.15(0.81-3.49)
3:65 0.35
4.48 (0.17-0:'4)'
P value 0.006 0.001
TABLE 2. Ratio of Total Choiesterol to High-Density Lipoprotein Cholesterol by Serum
Cotinine Group and Reported Exposure
Reported Exposure Serum Cotinine Concentration
<2.5 ng/mL i''_'.5 ng mL
n Ratio SD n Ratio SD
?V one 1124 3:47, 0.8-1 10 3.77, 0:76
Friends/sibs only 71 3.55 0.90 16 3."0 1.13
Mother, not father 49: 3.34 0.55 10 4.06 1.02
Father. not mother 33'. 3.64 0.78 13 4.22 1.04.
Both mother, and: father 37 3.68 0.85 8 3.91 1.02
TABLE 3. Multiple Regression Analysis of Ratio of Total Cholesterol to High-Density
Lipoprotein Cholesterol by Plasma Cotinine Concentration. Grouped, Adjusted for Several
Covariates'
Source of Variation, SS. df F Ratio P Value
Race 1."2 2 1.81 .165
Body mass index 6:64. 1 13.99 .000.
Cotinine grouped: <2.5
ng/mL vs _2:5 ng/mL 4.27 11 9.01 .003
Log triglyceride 44.W 11 92.79 .000
Error 160.29 338
' SS = sum of squares; N = 344: r = .54. Fortyseven patients with missing data on any
of the above variables are excluded.
TABLE 4. Multiple Regression Analysis of High-Density Lipoprotein Cholesterol by
Grouped Plasma Cotinine Levels Adjusted'for Several Covariates'
Source of'Variation SS d/, F Ratio P Value
Sex 515.20 1 5.-7 .01 -1
Log triglyceride 2346.87 1 26.27 .000
Bod'y mass index 1452.40 1 12.90 .000
Cotinine grouped: <2:5
ng/mL or >_2.5 ng/mL 427.50 1 4.79 .030
Error 34041.56 381
' N = 386; r=.35. Five patients with data missing on any of these variables are excluded.
The relationship betweem reported smoking hab-
its of parents, siblings, and friends and the ratio of'
TOTP.L-C/HDL-C was not statistically significant
(P =.18). There was a significant difference in the
ratio of TOTAL-C/HDL-C of adolescents whose
fathers smoked' compared with others (P' <_ .04).
When adjusted for multiple comparison bias, this
finding was no longer statistically significant.
There was no difference in the ratio of TOTAL-C/
H'DL-C of adolrescents whose mothers smoked com-
pared with others.
DISCUSSION
In this sample, passive exposure to tobacco
smoke as indicated by plasma cotinine coneentra-
tiom was associated with a higher ratio of TOTAL,
C/HDL-C and with a lower HDL-C concentration.
262 PASSIVE SMOKING AND LIPID~ LEVELS

Whemotlier factors were adjusted, passive exposure
to tobacco smoke was associated~ with an increased
ratio of TOTAL-C/HDL-C and decreased~ HDL-C
concentration of between 7% an& 9%. However,
compared~ with other factors such as BMI or tri-
glycerid'e concentration, the impact of passive
smoking on the ratio of TOTAL-C/HDL-C was
relativelv small.
We did not measure socioeconomic status of sub-
jects or obtain detailed dietary histories and there-
fore could not control for these variables. It is
possible that parents of lower economic status
smoked more frequently and~ provided their chil-
dren diets higher in cholesterol and saturated fats,
resulting in a secondary association ~ between serum
cotinine concentration and lipid! ratios. This seems
an unlikelv explanationl however, because the stu-
dents came from a relatively homogeneous com-
munity.
The association of lipid profiles with reported
smoking habits of parents. siblings, and''friends was
not statistically significant. There was an associa-
tion for adolescents whose fathers smoked com-
pared with~ others. But there was no association
with mothers" smoking. We did not predict this
pattern initially and the observation is inconsistent
with other reports, which have found a stronger
association with mothers' smoking." The most
likely explanatiom for thib pattern is a spurious
association. Parentheticalh, this pattern' also di-
minishes the likelihood that the observed associa-
tion between the lipid ratio and cotinine concentra-
t~ion was due to smoking mothers' providing a more
atherogenic diet. The association of passive expo-
sure to tobacco smoke with reduced HDL ,C and
elevated ratio of TOTAL-C/HDL-C is biologically
plausible, inasmuch as several investigators have
found that cigarette smoking results in~a lowering
of HDL-C.'-8-`-2' In one longitudinal study of' 36
female volunteers, investigators found that HDL-C
levels fluctuated with smoking status, increasing
when smoking ceased and decreasing when smoking
resumed." In another study, investigators reported
a dose-response relationship between smoking and
ratio of TOITAL-C/HDL-C:' The age- and weight-
adjusted ratio of TOTAL-C/HDL-C among 233
randomly selected families was 1,3% higher for
smokers than for nonsmokers, about 1.5 times that
seen in this study.
Several investigators have foun& suggestive evi-
dence of an increased risk of coronarv heart disease
mortality among adults passively exposed to to-
bacco smoke. Helsing et al-= found that death rates
from atherosclerotic heartdisease were 24 o to 31%
higher for nonsmokers living with smokers com-
pared with those living with nonsmokers. In a study
of nonsmoking women 50 to 79'years old! in south-
ern Calif'ornia, those whose husband's smoked had
a: 10-year mortalitv from ischemic heart disease that
was 2.1 times higher than those whose husband's
never smoked~ (P'< .10)~=''` In the Multiple Risk
Factor Intervention Trial, the effect of exposure t~o
tobacco smoke was assessed among 1245 married'
men aged 35 to 57, years.''' The relative risk for
nonsmoking men with smoking wives compared~
with those with nonsmoking wives was 2.1 f'or cor-
onary heart disease death ('.P = .19): and 1.48 for
f'atal or nonfatal coronar_v heart disease events 1 P
_ .13).
A recent study in 216 families of preadolescent
children fromithe Medical Colleage of Virainia twin
study found that children in the 105 families of
smoking parents had significantly lower HDL-C
and higher whole blood 2,3,d-phosphoglNeerate lev-
els thanichildTen in the 1111 nonsmoking families.="
The authors concluded that children, with long-
termlexposure to passive smoke may be at elevated
risk for the development of premature coronam~
heart disease.
The effect ofltobacco on lipi& levels provides one
plausible mechanism (among others such as platelet
aggregation, vasoactivity; and compromised oxygen,
transport) for the well-established' elevation of cor-
onary heart disease risk among smokers and' sug-
gests a mechanism for the possible increased coro-
nary heart' disease risk in passive smokers.
ACKNOWLEDGMENTS
Partial support was received from National Institute
of Environmental Health Sciences grants F+;08-F.S00161
and P30-E500928.
We thank Paul'Samuel. N1D. S. Bader. F. H. Gardner.
and L. Markowski for their assistance with various parts
of this study and B: North for typing the manuscript..
REFERENCES
1. US Dept of Health and Human Services. The Hralrh Cnn-
aequences of Smnkine. Ccrdioracculnr D«eosr .i Repnrr oj,
the tiurkenn General: Rockville- h1D: US Public Health
Service: 19R3. DHHS publicauon /PHS1 8a-5020a
2. Criqui MH. Wallace RS. µ`eics G. eral. Cigarette smokin>g
and plasma hi¢hidensttv lipoprotem cholesterol. Crrrularrnn
t9R0:6'2isuppl ta'V. ;(1.6
3. Bnschetto CS; Connor WE: Connor SL. 1latarazzo JG.
Plasma Gpid' and lipoprotein protilef ofi cigarette smokers
from randomlv selected families: enhancement of hyperiip-
idemia and depression of high density lipoprotein. Am J
Gordtol. 198.3:J2'6 5-680
4. Freedman DS. Srtnivatan SR. Shear CL., et al. Cigarette
smoking initiation and longitudinal chanees in serum lipids
and lipoproteins in earl$ adulthood: the Bogalusa Heart
~!,tudy..dm J EpidernroL 19R6:1L49O7-'219
6. Gordon T. Castelli WP. Hjortland'`:1C. Kannel N1'B' Dawler
T. High densm lipoprotein as a protective iacton against
coronary heamdisease. Am J Med: 1977:62:-0~-7,la,
ARTICLES 263

6. Wallace RB, AndersnmRA. Blood1ipidsd lipid~ related'meas-
ure> and the risk ot atherosclerotic cardiovascular disease.
Eptdrmtnl Rec. 198a 9:9;+-119
'. .larvis JJ. Pedoe-Tunstall H'. Feverabend C. Vessev C:,Sa-
loolee Y. Comparison of testF used to distinguish smokers
from nonsmokers..tm J Public Health, 198":--:143~-1438'
8. Hal'ev NJ, Axelrod CM. Tilton WA. Validation of self-
reported smoking behavior: biochemical analysis of cotinine
and thiocvanate. Am J Pub/ic Health. 1983:73:1'204-1207,
9. Tstmovianis GV: Jacotison MS. Feldinan JG, AntonioSan-
tiago SfT, Clutario BC. Nussbaum M. Shenker IR. Reduc-
tion in pulmonarv function and'inereased frequency,of cough
associated with passive smoking in teenage athletes. Ppdt-
arric., 1987:80::32-36
10. Knight GJ. Wilie P. Holman M& Haddow JE. Improved
125 1 radioimmunoassavl'or cotinine by selectiveremoval,of
bridge antibodies. C1in Chem. 1983:31:118-121
11. Chambers J, Cleveland V1': Kleiner B,,Tukev P. Graphical
1''
Methrxi, for Data Analvsu: Pacific Grove, CA: Wadsworth
Publishing Co: 1984
1Williamson DF. Kendrick JS. The box plot: a simple visual
method to interpret data: Ann: Intern Med. 1989:110:916-
921
1:;: tlcGilll R, TukeY .1Nt'. Larsen WA. Variations of box plots.
Am J'tatt..Yirian. 1978:32:12-16
14. Snedecor G. Cochran W: ,Statixttca1 Methud. 6th ed. Ames.
IA Ibwa:titate University Press: 1967:329-3130
1.i, Etzel RA. A' ('ohurt .titudv of Pa...ace Jmokint: and .Wfiddle
E.'ar t'jj i,iun.. in Chaldren. Chapel Hill. NC:, University of'
\ rth Carolina; 19li.i. Dissertation
1lll N'iikinson L. arxtat: The 5v.tem for Stattxtus. Evanston.
IL: SYSTAT: 1988
17. US Dept ol Health and HUman Services. Thr Health G'un
.aeyuence, uJ lntuiunton tiinoktnt;: .4 Reporr oFrhe .lur_enn.
General 1k'ashtngton.,DC: US Government Printing GJff ce.
1986, DHH>,publicauon ICDC1 8'-8:39A
18. Casteili WP. Garrtson RJl Wilson Pw'F: enal. Incidence of
coronan hean disease and lipoprotein cholesterol level.; the
Framingham Studt. JA'MA. 1986:256:''(*35-23ati.
19. Orchard'TJ. Rodgers M. Hedley AJ. Mnachell JRA. Serum
lipids in, a teenage population! Reographic- seasonal and
familial factors. Int J'1'ptdemtol. 1981:10i161-1 70
20. Halfon ST. Green MS. Heiss G. Smoking status and! lipid
levels in adults of different ethnic oniztns; the -lerusalem
Lipid Research Clinic Program. !nt J 6p dem,,,i
19R4:13:1-"-18:3
'?1. Moffatt RJ. Effects of cessation of smoking on serum Iipids
and high density hpoprotetn cholpsterol. A1hen,..cirru..o.
1988:74i8.i-89
22. Hetsing 1:J. Sandler DP, Comstock GX, Chee E. Heart
disease mortality imnonsmokers living with smokers. rim J
Epidemiol. 1988:127:916-922
23. Garland C. Barrett-Connor E. Suarez L. Criqui MH. 11'in-
Rard DL. Effects, of passive smoking on, tschemic heart
disease mortality of nonsmokers: a prospective studj,. Am J
Epidemaul. 1985:121l645-Fi50
24. Erratum. Am J f'ptdemiul.' 19R5:1--''?:1'1!1'2
25. Svendsen kH'. 1Culler LH. Martin MJl Ockene .lli. £ftect=
of passive smokin¢ in the Vtultipie Risk Factor Intervention
Trial. Am J Eptaemrol 1987:126: 78:1-795
26. Moskowitz WB, Mosteller Mwl, Schieken Rh1,. et al. Ltpo-
protein and'oxtgen transport alterations tn,passtve smoking:
preadolescent childrenr the MCV twin study. Crreulauun
1990:ri1t586-592
PATIENTS' GRADES HELP TO SET PAY FOR HEALTH-PLAN DOCTORS
A growing number of large health-care plans are asking patients to grade
their doctors: How long are they kept waiting in the office? Can the doctor be
reached at night and' on weekends? Does the doctor listen as patients describe
symptoms? How well is a treatment explained?
Some health maintenance organizations, or H.M.O.'s, use the grades as one
criterion in paying the doctors. Not surprisingly, many doctors think this is a
badidea.
At least 34 million Americans are enrolled~ in H'.M_O; plans, and more than
2.9 million are in plans that use patient evaluations to help determine doctors'
bonuses. The number of'such plans is steadily'increasing.
Freudenheim M. Patients' grades help to set pay for health-plan doctors. The New York Time..
May 26. 1990.
NOTED BY J.F.L., MD
264
PASSiVE SMOKING AND LIPID LEVELS
